mAbxience | CDMO



mAbxience is a global biopharmaceuticals expert, specialized in CDMO and the development and manufacturing of biopharmaceutical medicines, with high technology and innovative platforms that provide integrated solutions to meet any manufacturing need.
mAbxience CDMO business offers a complete service from small R&D and clinical batches to full commercial production:

  • Process & analytical development infrastructure from process development to optimization and scale up.
  • Robust processes following cGMP manufacturing guidelines.
  • Constantly expanding global capacities and capabilities with flexibility provided from 3L to 4,000L single-use bioreactors.
  • Internal and external Technology Transfer expertise.
  • Extensive knowledge of both fed batch and perfusion technology.
  • Cell line development capabilities.
  • Examples of product offerings include monoclonal antibodies, cytokines, chimeric proteins, recombinant hormones, adenoviral or bacilovirus vaccines, and other glycosylated recombinant proteins.

Contact us